Zinc sulfide lotion BPC 1979
Requires a prescription from a doctor or prescriber
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
Browse tools
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary. ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 1 · 1931–2026
Showing the 50 most relevant studies, sorted by most relevant.
K. J. Wedekind, A. E. Hortin, D. H. Baker
Journal of Animal Science, 1992
Keke Meng, Lei Chen, Guanghua Xia, et al.
Food Chemistry, 2021
Shimei Lin, Xin Lin, Yang Yang, et al.
Aquaculture, 2013
Beiping Tan, Kangsen Mai
Aquaculture, 2001
Oxford English Dictionary, 2023
Sophia Chan, Own Schreiber, Trevor Sando, et al.
2026
Electrodeposition of zinc is critical to enabling rechargeable zinc batteries. Historically, zinc batteries have employed zinc foil or powder zinc anodes, and the anode research has focused on improving the reversibility of zinc electrodeposition through a combination of material modifications and electrical controls. With breakthroughs in anode-free lithium batteries, an appealing possibility is to leverage the anode-free configuration. The very first step in such an operation is nucleation and growth of zinc on a substrate. Hence, to conclusively study how this early stage electrodeposition is influenced by factors such as electrolyte composition, substrate choice, and operating conditions, it is essential to obtain repeatable electrochemical signatures corresponding to nucleation and growth. Surprisingly, our experiments electrodepositing zinc on stainless steel find appreciable cell-to-cell variability across identical testing conditions. While we still do not conclusively understand the underlying mechanism(s) causing such variability, the present study quantifies the contributions to variability resulting from surface cleaning, formation step, and zinc counter electrode.
Abstract licence: CC BY-NC-ND 4.0
Khadijah Mohammad AL-Dhabyani, Abduh Mohammad Abdulwahab, Asma'a Ahmed AL Adhreai, et al.
2025
艳敏 刘
Metallurgical Engineering, 2024
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Structured knowledge from the free knowledge base
ATC classifications (Wikidata)
Linked open data from Wikidata (Q204898), a free and open knowledge base operated by the Wikimedia Foundation. Data is available under the Creative Commons CC0 1.0 Public Domain Dedication.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.